Bacteriocins are bacterial antimicrobial peptides with bactericidal activity against other bacteria. Staphylococcins are bacteriocins produced by staphylococci, which are gram-positive bacteria with medical and veterinary importance. In this study we are using two promoters from two plasmids to lysostaphin gene to change production of lysostaphin protein then killed Staphylococcus aureus and compared with pBluescript plasmid as control, pTrc99a get increased the production of lysostaphin protein while the pBAD30 are decreased the production in compared with pBluescript plasmid as control, at the same time both plasmid reported succeeded to lysostaphin expression and gave the protein with different concentration.
INTRODUCTION
The lysostaphin endopeptidase gene (lss) and the gene involved in lysostaphin resistance (lif) reside on plasmid pACK1 [1, 2] . Lss and lif are flanked by insertion sequences, suggesting that S. simulans biovar staphylolytic us received these genes by horizontal gene transfer [1] .
Class III bacteriocins include large peptides (Mr ≥ 25 kDa) which are generally heat-labile. This class of bacteriocins was further subdivided by Heng into two distinct groups: (i) the bacteriolytic enzymes (or bacteriolysins) and (ii) the nonlytic antimicrobial proteins [3] . Staphylococci have been shown to produce bacteriolysins, from which lysostaphin is considered to be the prototype. Lysostaphin is an extracellular enzyme secreted by S. simulans biovar staphylolyticus ATCC1362 [4] . The peptidoglycan of gram-positive microorganisms, an important component of the bacterial cell wall, is hydrolyzed at specific times and sites during physiological growth of the exoskeleton [5] . This is accomplished by murein hydrolases. Lysostaphin is one example of such enzymes, most of these enzymes display a domain structure [6] . In general, murein hydrolases harbor an N-terminal signal peptide followed by a second domain containing the enzymatic activity. In addition, these proteins harbor repeated sequences that flank either the N-or C-terminal side of the enzymatic domain [7] .
MATERIALS AND METHODS
Genomic DNA was isolated from S. simulans according to Sambrook and Russel [8] with some modification. DNA isolated from S. simulans used as a template for PCR amplification (tables 1, 2). The annealing temperature for this PCR was 53 °C. Then the PCR products were subjected to agarose gel electrophoresis, isolated and purified the DNA from gel by QIAquick Gel Purification Kit, this PCR product as template for this study,the primers used: 141  Forward: 5' GGT ACC ATG GCT GCA ACA CAT GAA CAT TCA 3'.  Reverse: 5' GAA TTC TCA CTT TAT AGT TCC CCA AAG AAC 3'.
Stage
Step (table 3) . Run the plasmid in the gel, isolated and purified from the gel by Gel Extraction Kit. The PCR product were subjected to electrophoresis, isolated and purified the DNA from gel by extraction of DNA from agarose gels. After that the lysostaphin gene was cut as shown in table (4) . Then cleaned the DNA (lysostaphin gene) from the few bp which formed after the cut by PCR Purification Kit. Clones were done to study the promoter effect, the cloning were done between cuter plasmid with pTrc99a plasmid cuter first times and with pBAD30 plasmid cuter other times, those happened by: 1. Ligated lysostaphin gene digested by Kpn I and EcoR with pTrc99a digest by Kpn I and EcoR I as described and transformed to rubidium chloride competent cells E. coli DH5α. 2. Ligated lysostaphin gene digested by Kpn I and EcoR with pBAD30 digest by Kpn I and EcoR I as described and transformed to competent cells E. coli DH5α. For all cases, colonies were replica-plated onto fresh LB solid medium, containing Ampicillin 100 µg/ml, incubated overnight at 37 C. Transformants were confirmed by PCR analysis, restriction of harboured plasmids then done colony PCR, this protocol is designed to quickly insert plasmids (constructive plasmid) screening E. coli DH5α colonies. Table ( 3) The substances and quantity of digestion pTrc99a and pBAD30 by Kpn 
RESULTS AND DISCUSSION
Figure (3) showing the PCR product result from S. simulans after running the product in the gel. This figure showed the band of product (lysostaphin gene) less then (750) bp. The result appeared the size of lysostaphin gene accepted to [10, 11, 12] . Table ( 
S. aureus

141
The concentration of lysostaphin protein from cloned bacteria by His-tag column was shown in table (5) , also this table showed the lysostaphin from pTrc99a plasmid, and lysostaphin from pBAD30 plasmid. Figure (7) showed SDS-PAGE analysis of proteins by standard techniques, the figure showed one band of protein, the molecular weight of lysostaphin in all lanes were about 27,000 Dalton, it is agreed with [16, 12] .
Our results was find very high variety of effect and concentration of lysostaphin protein according to plasmid types, that is mean we can change the effect and concentration if we change the promoter (plasmid) of gene. Lysostaphin activity against staphylococci is due to its lysis capability of the peptidoglycan of bacterial cell walls [15, 16] . The target of the lysostaphin is the pentaglycine cross-bridge of the peptidoglycan [17] . S. aureus and other staphylococcal species are composed of five glycine (Gly) residues [18, 19] . Lysostaphin has the ability to cleave specifically between the third and the fourth Gly residues of the pentaglycine cross-bridge [20, 17] . The peptidoglycan of staphylococcal species is relatively resistant to lysostaphin containing higher amount of serine (Ser) than Gly [21] .
Conclusions:
The research has arrived the conclusions, E. coli cloned with lysostaphin gene are very effective against S. aureus. pTrc99a get increased the production of lysostaphin protein while the pBAD30 are decreased the production in compared with pBluescript plasmid as control, at the same time both plasmid reported succeeded to lysostaphin expression and gave the protein with different concentration.
Recommendations:
The research recommends try to transport lysostaphin gene to eukaryotic system by transgenic method for a normal expression of this gene in second generation, and use lysostaphin in pharmaceutical in addition to antibiotics by to produce new successful antibiotics as a treatment of S. aureus. 
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